Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease.

@article{Chaparro2012SystematicRA,
  title={Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease.},
  author={Mar{\'i}a Chaparro and Iv{\'a}n Guerra and P Mu{\~n}oz-Linares and Javier P Gisbert},
  journal={Alimentary pharmacology & therapeutics},
  year={2012},
  volume={35 9},
  pages={971-86}
}
BACKGROUND The associations between clinical efficacy and infusion reactions with anti-TNF-α drug levels and the presence of antibodies against the drug have been described. However, the clinical utility of these tests in routine clinical practice remains unclear. AIMS To examine the clinical significance of the development of antibodies against anti-TNF-α drugs and the relationship between the efficacy of these drugs and their serum levels. We also studied the clinical utility of testing for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease

W Afif, EV Jr.Loftus, WA Faubion
Am J Gastroenterol • 2010
View 5 Excerpts
Highly Influenced

The effect of dose escalation on through levels in patients who lost rresponse to infliximab

S Vermeire, F Gabriels, V Ballet
Gut • 2010
View 3 Excerpts
Highly Influenced

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2004
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…